反応式
[CH2:1]([S:3][C:4]1[N:9]([CH3:10])[C:8](=[O:11])[N:7]([CH3:12])[C:6](=[O:13])[C:5]=1[CH:14]=O)[CH3:2].Cl.[CH2:17]([O:24][NH2:25])[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1>>[CH2:17]([O:24][N:25]=[CH:14][C:5]1[C:6](=[O:13])[N:7]([CH3:12])[C:8](=[O:11])[N:9]([CH3:10])[C:4]=1[S:3][CH2:1][CH3:2])[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1参加物
3
実験手順
The process described in Method A was followed. 6-(Ethylthio)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde (Example 23, Step 1) (0.070 mg, 0.30 mmol) and O-benzyl-hydroxylamine hydrochloride (0.063 mg, 0.40 mmol) were used to obtain the title compound.
出典と根拠
- ORDレコード
- ord-e53f4ee389a449ed958feb11973d33af
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536210B2
関連ノート
読み込み中…